Fig. 3From: Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinomaHCC recurrence rates among groups according to the IFN-γ producing NK cell proportion at baseline (A) and 1 month after treatment (B). Group 1, patients with IFN-γ producing NK cell proportion ≥ 45%; Group 2, patients with IFN-γ producing NK cell proportion < 45%. HCC, hepatocellular carcinoma; IFN, interferon; NK, natural killerBack to article page